For too long, the development of innovative therapies for newborns has lagged behind that of other populations, such as adults and older children. This is due to a myriad of factors, ranging from the complexity of the current regulatory system to the inadequately aligned incentives. But recently proposed legislation from the bipartisan pair of Sens. Bob Casey (D-Pa.) and Bill Cassidy (R-La.) marks a strong and historically important step in the right direction. The National Association of Neonatal Nurses urges members of Congress and dedicated parents around the country to show their support for S. 2041, The Promoting Life-Saving Therapies for Neonates Act of 2015, and ensure that newborns are given the best possible treatment that modern medicine can provide.